Skip to main content
See every side of every news story
Published loading...Updated

Why Is Scholar Rock Stock Trading Lower On Monday? - Scholar Rock Holding (NASDAQ:SRRK)

Scholar Rock shares dropped 11.26% after the FDA cited Catalent Indiana with an official action indicated classification impacting Scholar Rock's biologics license application.

Summary by Benzinga
Scholar Rock Holding Inc. (NASDAQ:SRRK) stock is falling on Monday with a session volume of 8.19 million versus the average volume of 2.08 million, as per data from Benzinga Pro. In a press release on Monday, the company stated that on Friday, October 10, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Catalent Indiana, LLC, a subsidiary of Novo Nordisk A/S (NYSE:NVO). The FDA inspected the facility in July and determined that t…

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Monday, October 13, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal